William A. Wexler - 09 Aug 2022 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role
Director
Signature
/s/ William A. Wexler
Issuer symbol
CMRA on OTC
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
11 Aug 2022, 18:14:52 UTC
Previous filing
03 Aug 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase) Award $0 +14,200 $0.000000 14,200 09 Aug 2022 Common Stock 14,200 $2.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest over three (3) years, with thirty-three and one-third percent (33 1/3%) of the shares of Common Stock underlying the option vesting on August 9, 2023 and the remainder vesting in equal monthly installments thereafter.